FDA publishes final unique device identifier rule for medical devices
The US Food and Drug Administration (FDA) issued the final unique device identifier (UDI) rule on 24 September 2013, following up on the draft rule previously circulated by the FDA on 3 July 2012.
With limited exceptions, the rule requires that medical devices are labelled with a UDI in both a plain-text format and in a format that uses automatic identification and data capture (AIDC) technology, such as a barcode or radio-frequency identification. The UDI must be placed on the medical device labels and packaging and the UDI must include two parts: both a device identifier and a production identifier.
The device identifier corresponds to the version or model of the device, and the production identifier identifies the specific device through means such as the serial number, lot, batch, expiration date or date of manufacture. For a human cell, tissue or cellular and tissue-based product (HCT/P) regulated as a device, the production identifier can include the distinct identification code required for these devices under 21 C.F.R. §1271.290(c)…
If you are registered and logged in to the site, click on the link below to read the rest of the Hogan Lovells briefing. If not, please register or sign in with your details below.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Hogan Lovells
News from The Lawyer
Briefings from Hogan Lovells
The decision of the US Court of Appeals has raised questions about how issuers should present their disclosures on conflict minerals under Exchange Act Rule 13p-1 and Form SD.
An interesting judgment was delivered by the Honourable J Majiki on 19 November 2013 in the Eastern Cape High Court, Port Elizabeth.
Analysis from The Lawyer
As international firms question their future in these small, closely linked markets, local lawyers too are eyeing the business environment with caution
Beyond the headline infrastructure projects, UK construction work is still recovering from the clobbering it took during the slump